Prosecution Insights
Last updated: October 25, 2026

Agribody Technologies LLC

Technology area: Biotechnology & Pharmaceuticals

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Agribody Technologies LLC has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are split between 2 distinct examiners and 2 distinct art units. DELEO, VICTORIA LYNN is the busiest examiner, currently managing 1 of the pending office actions.

The involvement of the distinct examiners across the distinct art units requires the company to manage separate prosecution strategies. This structure means each application is subject to a unique review process within the Biotechnology & Pharmaceuticals sector.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (50%)
1
Easy (50%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§112 only1 (50%)
Double-patenting + other1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DELEO, VICTORIA LYNN 1 41.4% -44.4%
KINGDON, CATHY 1 80.3% +2.6%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18325749 Plants with Modified Deoxyhypusine Synthase Genes KINGDON, CATHY —

Top Art Units

Art UnitApps
1662 1
1663 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18881220 Plants with Modified Deoxyhypusine Synthase Genes DELEO, VICTORIA LYNN 1662 §112 Non-Final OA — Pending Jan 03, 2025
18325749 Plants with Modified Deoxyhypusine Synthase Genes KINGDON, CATHY 1663 §103§112DP Final Rejection — Pending May 30, 2023

Managing Agribody Technologies LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Agribody Technologies LLC have?

Agribody Technologies LLC has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Agribody Technologies LLC applications?

Victoria Lynn Deleo has the most, with 1 of Agribody Technologies LLC's pending office actions.

What technology area are Agribody Technologies LLC's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month